Researchers determined the prevalence VEXAS in patients with relapsing polychondritis, assessed clinical, laboratory, and immunologic features, and developed a clinical algorithm to inform genetic screening for VEXAS in this population.
Researchers studied the association between steroid therapy and glucocorticoid toxicity in patients with ANCA-associated vasculitis.
Researchers described diagnostic delays and the factors associated with time to diagnosis in patients with vasculitis.
Authors presented the case of a 48-year-old woman with rheumatoid arthritis, newly diagnosed microscopic polyangiitis, and a recent COVID-19 infection who stopped taking immunosuppressive therapy.
Researchers aimed to estimate the mortality rates of primary systemic vasculitis and its geographic distribution, using recent population data in the US.
Researchers assessed the role of trimethoprim/sulfametoxazole in reducing relapse rate in patients with granulomatosis with polyangiitis and infection risk in patients with ANCA-associated vasculitis.
In an open-label study of the GiACTA trial, investigators studied the long-term effect of tocilizumab in patients with giant cell arteritis.
The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed consensus treatment plans for severe pediatric ANCA-associated vasculitis to evaluate comparative effectiveness and safety.
Treatment with rituximab and immunoglobulin levels may increase risk for COVID-19-related death in ANCA-associated vasculitis.
Researchers assessed the association between Behçet disease and psoriasis and psoriatic arthritis, using data from the National Health Insurance Service of Korea.